Status:
COMPLETED
The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Radiographic Contrast Agent Nephropathy
Aortic Valve Stenosis With Insufficiency
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
Evaluating whether forced diuresis with matched hydration will reduce the risk of contrast induced nephropathy in patients undergoing Transcatheter Aortic Valve Implantation (TAVI).
Detailed Description
Reducing Acute Kidney Injury in TAVI Patients (REDUCE trial) The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During Transcatheter Aortic Valve Implantation (T...
Eligibility Criteria
Inclusion
- Subject is 65 years old who is able and willing to give an informed consent.
- Patients undergoing planned trans-femoral TAVI.
- Calculated eGFR below 60ml/min/1.73m2 (MDRD)
Exclusion
- History of acute coronary syndrome in the past 30 days.
- History of congesting heart failure with left ventricular ejection fraction \<30% or exacerbation in the past 30 days.
- Current dialysis treatment.
- Known furosemide hypersensitivity.
- Contraindications to placement of a Foley catheter in the bladder.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 22 2019
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01866800
Start Date
June 1 2013
End Date
May 22 2019
Last Update
May 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Medical Center
Tel Aviv, Israel